Abstract
Aim Glaucoma and dementia are both age-related neurodegenerative diseases with significant societal impact. Despite evidence suggesting an association between normal tension glaucoma (NTG) and dementia, lack of consensus remains due to conflicting reports. This cross-sectional cohort study administered a battery of neurocognitive tests targeting executive function, learning, and memory in subjects with NTG and unaffected controls to evaluate aspects of cognition impacted by dementia.
Methods Fifty NTG and 50 control patients ≥ 50 years of age were recruited from the UCSF Department of Ophthalmology. Demographic data and glaucoma parameters were extracted from electronic medical records for both groups. Tests of executive function (Executive Abilities: Measures and Instruments for Neurobehavioral Evaluation and Research [EXAMINER]) and learning and memory (California Verbal Learning Test–Second Edition [CVLT-II]) were administered to both NTG and Controls. Race, handedness, best-corrected visual acuity, maximum intraocular pressure, optic nerve cup-to-disc ratio, visual field and optic nerve optical coherence tomography parameters, and a measure of general health (Charlson Comorbidity Index) were compared between NTG and Controls as well as within NTG subgroups. Multivariate linear regression was used to compare group performances on the EXAMINER battery and CVLT-II while controlling for age, sex, and years of education.
Results NTG and Controls were comparable with respect to age, sex, race, education, handedness, and the Charlson Comorbidity Index (p>0.05 for all). Performance on the EXAMINER composite score and the CVLT-II did not differ between NTG and Controls (p>0.05 for both).
Conclusions This is the first prospective study in which the cognitive function of subject with NTG were evaluated using a comprehensive, computerized neurocognitive battery. Subjects with NTG subjects did not perform worse than unaffected controls on tests of executive function, learning, and memory. Results do not support the hypothesis that individuals with NTG are at higher risk for cognitive dysfunction and/or dementia.
- Low Tension Glaucoma
- Mental Status and Dementia Tests
- Neurodegenerative Diseases
- EXAMINER
- CVLT-II
- Executive Function
- Learning and Memory
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors report no conflicts of interest and nothing to disclose. The authors alone are responsible for the content and writing of the paper.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB number is 13-12318 This submission was eligible for expedited review by the IRB as: Category 5: Research involving materials (data, documents, records, or specimens) that have been collected, or will be collected solely for nonresearch purposes (such as medical treatment or diagnosis) Category 7: Research on individual or group characteristics or behavior (including, but not limited to, research on perception, cognition, motivation, identity, language, communication, cultural beliefs or practices, and social behavior) or research employing survey, interview, oral history, focus group, program evaluation, human factors evaluation, or quality assurance methodologies Data analysis phase: This study is in data analysis and involves no greater than minimal risk for the population being studied. This study is eligible for (1) expedited review and (2) transition to the 2018 Common Rule. As such, it no longer has an expiration date.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Commercial Relationships: None.
Data Availability
The authors confirm that the data supporting the findings of this study are available within the article [and/or]can be shared by corresponding author upon request.
